| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000021443 |
| Receipt No. | R000024731 |
| Official scientific title of the study | Effect of Smoking Status on the Incidence of Pancreatic Cancer Concomitant with Intraductal Papillary Mucinous Neoplasm, Invasive Intraductal Papillary Mucinous Neoplasm |
| Date of disclosure of the study information | 2016/04/15 |
| Last modified on | 2017/02/22 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Effect of Smoking Status on the Incidence of Pancreatic Cancer Concomitant with Intraductal Papillary Mucinous Neoplasm, Invasive Intraductal Papillary Mucinous Neoplasm | |
| Title of the study (Brief title) | Effect of Smoking Status on the Incidence of Pancreatic Cancer Concomitant with IPMN,Invasive IPMN
|
|
| Region |
|
|
| Condition | ||||
| Condition | intraductal papillary mucnous neoplasm:IPMN | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Malignancy | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | The aim of this study is to elucidate the association of smoking status with the incidence of pancreatic cancer with IPMN and invasive IPMN. |
| Basic objectives2 | Bio-availability |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | the association of smoking status with the incidence of pancreatic cancer with IPMN and invasive IPMN |
| Key secondary outcomes | the association offamily history of pancreatic cancer(presence, absence), diabetes mellitus(presence, absence), alcohol consumption(more than 50g/day, less than 50g/day), BMI(more than 25, less than 25), macroscopic type of IPMN ,diameter of IPMN , nodule in IPMN (presence, absence),diameter of main pancreatic with the incidence of pancreatic cancer with IPMN and invasive IPMN |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | This study included patients with surgically resected IPMNs and PDAC concomitant with IPMN in Kobe university hospital between April 2008 to October 2015 | |||
| Key exclusion criteria | nothing | |||
| Target sample size | 124 | |||
| Research contact person | |
| Name of lead principal investigator | Atsuhiro Masuda |
| Organization | Kobe University Graduate School of Medicine
|
| Division name | Division of Gastroenterology |
| Address | 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, Japan |
| TEL | 078-382-6305 |
| atmasuda@med.kobe-u.ac.jp | |
| Public contact | |
| Name of contact person | Takashi Nakagawa |
| Organization | Kobe University Graduate School of Medicine |
| Division name | Division of Gastroenterology |
| Address | 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, Japan |
| TEL | 078-382-6305 |
| Homepage URL | |
| tnaka@med.kobe-u.ac.jp | |
| Sponsor | |
| Institute | Kobe University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | to elucidate the association of smoking status with the incidence of PDAC with IPMN and invasive, we will investigate retrospectively patients with surgically resected IPMNs and PDAC concomitant with IPMN. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024731 |